02-May-2019 | Zion Market Research
Zion Market Research has published a new report titled “Blood Screening Market By Technology (Rapid Tests, Nucleic Acid Test, Enzyme-Linked Immunosorbent Assay, Next Generation Sequencing, and Western Blot Assay), By Products and Services (Reagents & Kits, Standards & Controls, Buffers, Nucleotides & Solutions, Immunosorbents, Conjugates, Sample Diluents & Wash Solutions, Software & Services, Enzymes & Polymerases, Probes & Primers, Labeling & Detection Reagents, Controls, Substrates, and Instruments), and By End-User (Blood Banks and Hospitals): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2018–2025”. According to the report, the global blood screening market was around USD 2,133 million in 2018 and is expected to reach approximately USD 3,989 million by 2025, at a CAGR of around 10.23% between 2019 and 2025.
Blood is a red liquid with suspended proteins and cells and contains white blood cells, red blood cells, and platelets. Blood plays a key role in the transport of oxygen and nutrients to the cells in the entire body. Blood screening is the process of blood examination for a particular disease. The early identification of diseases helps in curing and monitoring diseases. Blood screening is essential for the diagnosis of diseases, such as cancer, HIV (Human Immunodeficiency Virus), etc. Rising health expenditure, increasing acceptance of nucleic acid testing, and technological advancements witnessed in the blood screening process are driving the blood screening market growth globally. Initiatives undertaken by various governments and government associations for healthcare are creating new growth opportunities for the global blood screening market. However, compound regulatory frameworks, shortage of skilled workforce, and the existence of substitute technologies may hamper the global blood screening market growth.
Browse the full “Blood Screening Market By Technology (Rapid Tests, Nucleic Acid Test, Enzyme-Linked Immunosorbent Assay, Next Generation Sequencing, and Western Blot Assay), By Products and Services (Reagents & Kits, Standards & Controls, Buffers, Nucleotides & Solutions, Immunosorbents, Conjugates, Sample Diluents & Wash Solutions, Software & Services, Enzymes & Polymerases, Probes & Primers, Labeling & Detection Reagents, Controls, Substrates, and Instruments), and By End-User (Blood Banks and Hospitals): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/blood-screening-market
The technology segment of the global blood screening market includes rapid tests, nucleic acid test, enzyme-linked immunosorbent assay, next generation sequencing, and western blot assay. The nucleic acid test segment is sub-divided into transcription-mediated amplification and real-time polymerase chain reaction. The enzyme-linked immunosorbent assay is bifurcated into platform and generation. On the basis of platform, the enzyme-linked immunosorbent assay segment is sub-divided into chemiluminescence immunoassay, colorimetric immunoassay, and fluorescence immunoassay. The next generation segment further includes first generation, second generation, third generation, fourth generation, and above. On the basis of product and services, the blood screening market is segmented into standards and controls, reagents and kits, buffers, immunosorbents, conjugates, sample diluents and wash solutions, nucleotides and solutions, enzymes and polymerases, software and services, controls, probes and primers, substrates, instruments, and labeling and detection reagents. By end-user, the market includes blood banks and hospitals.
By region, North America is projected to lead the blood screening market globally in the future due to various technological advancements made in the blood screening process. The Asia Pacific blood screening market is anticipated to grow at the highest pace over the estimated time period. The European blood screening market is anticipated to show momentous growth due to the increasing number of blood transfusion procedures and complex surgeries performed across the region. The Middle East and Africa and Latin America are projected to show moderate growth in the future.
Some major players operating in the global blood screening market are Grifols, Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Bio-Rad Laboratories, bioMérieux, Ortho Clinical Diagnostics, Siemens Healthineers, Roche Diagnostics, and Becton, Dickinson, and Company.
This report segments the global blood screening market into:
Global Blood Screening Market: Technology Analysis
Global Blood Screening Market: Products & Services Analysis
Global Blood Screening Market: End-User Analysis
Global Blood Screening Market: Regional Analysis
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651